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Hua Xu1, MuMin Shao1, HuiLi Sun2 and ShunMin Li2*Abstract
Primary mesenchymal chondrosarcoma of the kidney is rare, and it shows distinct undifferentiated tumor cells and
well differentiated cartilagenous components. Also assident infiltrating urothelial carcinoma of the ureter is an
extremely rare cancer. We report a case of primary mesenchymal chondrosarcoma occurring in the left kidney with
an ipsilateral and distinct distal ureteric implant, and a coexisting infiltrating urothelial carcinoma of the ureter in a
64-year-old man. Histopathological examination and immunohistochemical studuies showed the classic features of
mesenchymal chondrosarcoma in kidney, as well as a few infiltrating urothelial in ureter. Multitarget fluorescence in
situ hybridization (FISH) suggested that the development of the urothelial carcinoma in the ureter may be triggered
or induced by the chondrosarcoma component. The patient died 2 month after left nephro-ureterectomy. This is
the first reported case of a primary mesenchymal chondrosarcoma of the kidney with coexisting infiltrating
urothelial carcinoma of the ureter.
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vs/1522835667751019
Keywords: Mesenchymal chondrosarcoma, Urothelial carcinoma, Kidney, UreterBackground
Mesenchymal chondrosarcoma was first reported by
Lichtenstein and Bernstein in 1959 [1]. This malignant
tumor mostly arises in the skeleton, and one third of the
cases arise in the soft tissue and other organs. Extraskele-
tal mesenchymal chondrosarcoma is rare, and uaually
arises in the head and neck region, followed by the lower
extremity, the trunk and the retroperitoneum. Primary
mesenchymal chondrosarcoma of the kidney is extremely
rare, and the first case was published 25 years ago by
Malhotra [2]. To date, there are only seven cases of pri-
mary renal chondrosarcoma reported in the English lit-
erature [2-7]. We report another case of mesenchymal
chondrosarcoma of the kidney with synchronous implant
and a coexistent infiltrating urothelial carcinoma of the
ureter firstly.* Correspondence: shunminli@126.com
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A 64-year-old man presented with gross hematuria and
vague pain in the left loin. His medical history was unre-
markable. Physical examination revealed percussion pain
over the left kidney region. Urinalysis showed positive
for protein and red blood cells. Abdominal B ultrasonog-
raphy revealed left hydronephrosis and a hypoechoic
mass in the inferior segment of the left ureter. Magnetic
resonance imaging (MRI) confirmed left hydronephrosis,
a low signal mass in the upper pole of the kidney, and
another mass with high T1, low T2 signal in the inferior
segment of the left ureter. Imaging examination showed
no abnormality elsewhere. A clinical diagnosis of malig-
nancy of the left kidney and the ureter was made, for
which a left nephro-ureterectomy was performed.
Gross examination of the nephro-ureterectomy speci-
men showed pale grayish solid tumor in the enlarged
kidney, and the tumor measured 11 × 8× 6 cm, causing
dilatation of the renal pelvis. The tumor invaded the cor-
tex, medulla, adeps renis and involved 90% of the total
kidney, resulting in distortion (Figure 1a). And aThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Nephro-ureterectomy specimen showing the large tumor nodule in the kidney. Gross examination showed the tumour involved
the whole kidney cortex, medulla, capsule (red arrow) and adeps renis (green arrow) and the ureter was distended by a narrow solid tumor mass
(white arrow).
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was present in the inferior segment of the left ureter,
being distinct from the tumor in the renal (Figure 1b).
Microscopically, the renal mass showed a biphasic infil-
trative growth pattern with the typic characteristic of
mesenchymal chondrosarcoma. It consisted of undiffer-
entiated spindle to oval shaped cells, with hyperchro-
matic nuclei and scanty cytoplasm mainly arranged in
Ewing’s sarcoma-like, lamellar or hemangiopericytoma-
like patterns. Other areas demonstrated well defined
islands of cartilage. The transformation from the undif-
ferentiated cells to the cartilage cell was abrupt and
interlaced(Figure 2a,2b). The tumor had invaded the
renal pelvis, but there were no evidence of papillary le-
sion or underlying urothelial carcinoma.
The tumor in the distal ureter was microscopically
similar to that in the kidney, with the typical biphasic
mesenchymal chondrosarcoma component , which con-
stituted bulk of the tumor mass. However, there was a
small component exhibiting features of urothelial carcin-
oma. The urothelial carcinoma showed infiltrative nests,
of moderate cytological grade, and displayed foci of
squamous cell differentiation with some degree of
keratinization (Figure 3a,3b). The mucosa adjacent to
the tumor showed no evidence of underlying dysplasis
or carcinoma in-situ. Extensive sampling of the kidney
tumor did not identify a carcinomatous component. Vas-
cular invasion of the chondrosarcoma was detected , but
no carcinomous metastasis was detected.
Immunohistochemical staining showed the poor-
differentiated tumor cells and cells within the cartilagin-
ous areas in both the kidney (Figure 2c,2d,2e,2f ) and the
ureter were positive for Vimentin, CD99and S-100 pro-
tein but were negative for cytokeratin, epithelial mem-
brane antigen ,E-cadherin, Leu7, neuron-specific enolase,
SMA, CD34, p63 and desmin. The poor-differentiated
tumor cells displayed a higher Ki-67 index than those in
the well-differentiated cartilaginous areas. The urothelial
carcinoma component within the ureter, the tumor cells
were positive for cytokeratin (Figure 3c), epithelialmembrane antigen, E-Cadherin and negative for Vimen-
tin (Figure 3d), S-100 and CD99, enhancing the contrast
of synchronous urothelial carcinoma from mesenchymal
chondrosarcoma. For FISH analysis, labeled probes spe-
cific for chromosomes 3, 7, 17 and for the p16 (9p21)
gene (GP Medical Technologies,Ltd, Beijing, China) were
used. Two DNA- probes were mixed together as a set
double-target FISH and paired as follows: chromosome 3
(fluorescein isothiocyanate) and chromosome 7 (rhoda-
mine), chromosome 17 (fluorescein isothiocyanate) and
p16 (rhodamine).In both the urothelial carcinoma and
mesenchymal chondrosarcoma components, aneuploidy
of chromosome 3, 7 and 17 and loss of p16 gene were
observed (Figure 4, and Tables 1, 2).
The patient died of the widespread metastases two
months after surgery, autopsy was not performed.
Conclusions
On review of the literature, only seven cases of renal
mesenchymal chondrosarcoma have been reported. Here
we first describe an interesting case of renal mesenchy-
mal chondrosarcoma with a synchronous ureter implant,
which was intimately mixed or in collision with an
urothelial carcinoma. The biphasic growth pattern of
highly cellular undifferentiated tumor cells, with islands
of differentiated cartilage is rather characteristic of
mesenchymal chondrosarcoma [8]. Such a distinctive
morphology, with the absence of osteoid formation set
mesenchymal chondrosarcoma apart from small cell
osteosarcoma, Ewing’s sarcoma, dedifferentiated chon-
drosarcoma, and hemangiopericytoma.
It is important to note that the absence of epithelial
component and of an underlying urothelial carcinoma
from an extensively sampled tumor, is an indication of
pure mesenchymal chondrosarcoma arising from the
kidney. The lack of immunoreactivity for epithelial mar-
kers, suck as cytokeratin AE1/E3, EMA and E-cadherin
lends further support to it. Moreover, the tumor located
in the renal parenchyma and distant inferior ureter, not
in the calyx and pelvis, the relatively normal collecting
Figure 2 The renal mass consisting of sheets of undifferentiated mesenchymal cells (H&E, 2a), and scattered well demarcated islands
of differentiated cartilage (H&E, 2b). Both the undifferentiated tumor cells and cartilaginous islands were immunoreactive to Vimentin (2c), to
S-100 protein (2d) and to CD99 (2e), and not to cytokeratin (2f).
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and the distal ureteric mesenchymal chondrosarcoma is
keeping with the label of tumor implant.
As for the lower ureteric tumor, the transition between
the large bulk of mesenchymal chondrosarcoma and the
relatively small urothelial carcinoma was abrupt. More-
over, there was no apparent transition between the car-
cinoma and the ureteric mucosa or epithelium, which is
free of dysplasia or neoplastic field changes. Such an ob-
servation support a collision of two separate tumors in
the lower ureter. There were some reports on a collision
of separate tumors in the same location of the urinary
system [9,10]. While only vascular invasion is observed
with mesenchymal chondrosarcoma, and no observed
with urothelial carcinoma, such a pattern of metastasisdoes not necessarily imply that the two malignancies are
biologically distinct.
From the view of histogenesis, some groups have pro-
posed that a cell could generate a precursor with greater
potential than the cell from which it derives, or transdif-
ferentiation, that allows cell lineage switch. Several such
multipotential malignant sarcoma have been reported,
for example osteosarcoma and Ewing’s sarcoma with
epithelial differentiation [11]. The primary tumor cell in
mesenchymal chondrosarcoma represents a very primi-
tive mesenchymal cell type. Daniel Rubio clearly demon-
strated a novel mesenchymal-epithelial transition (MET)
associated epithelial tumorigenesis [12]. And a work
showing MET in vitro using a chondrosarcoma tumor




Figure 3 The ureteric tumor revealing a mesenchymal chondrosarcoma, similar to that in the kidney (black arrow), and in addition a
synchronous infiltrative urothelial carcinoma (white arrow) (3a),with foci of squamous differentiation and keratinization(3b). The
urothelial carcinoma (white arrow) was positive for cytokeratin (3c) and negative for Vimentin (3d); while the mesenchymal chondrosarcoma
(black arrow) was negative for cytokeratin (3c) and positive for Vimentin (3d).
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portedly acquire some epithelial characteristics, and
there is an epigenetic switch associated with an MET-
like phenomenon that accompanies chondrosarcoma
progression [13]. These observations support the hy-
pothesis that not all carcinomas are derived from epithe-
lial cells. In our present case, both the urothelial
carcinoma and the mesenchymal chondrosarcoma all
exhibited polysomy of chromosome 3, 7 and 17, the dif-
ference was significant (p < 0.05, chi-square test, SPSS
13.0), and loss of p16 gene by fluorescence in situFigure 4 Aneuploidy of chromosome 3(green) and 7(red) in urothelia
p16 gene(red) in urothelial carcinoma (4b).hybridization (FISH). The development of urothelial car-
cinoma had been linked to chromosomal instability,
especialy chromosome 3,7and 17 and partial or complete
loss of chromosome 9 ( p16 locus) [14] . It is thus con-
ceivable that the development of urothelial carcinoma
may be triggered or induced by chondrosarcoma, espe-
cially since both shared the same clonal origin.
The cytogenetic and molecular mechanism on renal
mesenchymal chondrosarcoma is indefinite. Lee AF
showed that, in contrast to Ewing sarcoma, small cell
osteosarcoma and mesenchymal chondrosarcoma lackl carcinoma (4a). Aneuploidy of chromosome17(green)and loss of the
Table 1 The ratio of gene copy numbers to chromosome
3,7and 17 centromere by FISH probes in urothelial
carcinoma and mesenchymal chondrosarcoma
Urothelial carcinoma Mesenchymal chondrosarcoma
chromosome 3 7 17 3 7 17
monosomy(%) 8 15 8 12 13 15
disomy(%) 35 42 29 51 61 46
trisomy(%) 27 23 40 18 16 28
polysomy(%) 30 20 23 19 10 11
aneuploidy(%) 65☆ 58△ 71◇ 49☆ 39△ 54◇
Relationship between aneuploidy of chromosome 3,7, 17 of urothelial
carcinoma and mesenchymal chondrosarcoma. ☆x2 = 5.22,p = 0.022.
△x2 = 7.23,p = 0.007. ◇x2 = 6.17,p = 0.013.
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tivity. FLI-1 is therefore useful in the differential diagno-
sis of small round blue cell tumors of the bone [15].
Wang L described the novel HEY1-NCOA2() fusion
appears to be the defining and diagnostic gene fusion in
mesenchymal chondrosarcomas [16]. Nevertheless, the
progression mechanism of renal mesenchymal chondro-
sarcoma remains to be developed investigated.
The prognosis for mesenchymal chondrosarcoma aris-
ing from bone and soft tissue is dismal. Of the seven
cases of primary renal mesenchymal chondrosarcoma
reported in the English literature, four cases developed
local recurrences or metastases at an interval of 1 month
to 2.5 years after surgical intervention. In the current
case , whether the ureteric tumor represented a direct
intraluminal seeding and ‘implant’ ,or a second primary
arising from a background with field change remains
speculative, but given its highly aggressive nature, it
would be tempting to postulate that this highly aggres-
sive tumor shows a propensity for intra-calyxceal spread.
The autopsy was not performed, however vascular mes-
enchymal chondrosarcoma metastasis detected may im-
plicate mesenchymal chondrosarcoma, rather than
carcinoma as the lethal metastasis.Consent
Written informed consent was obtained from the next




single signal 36 46
double signals 39 39
three signals 0 0
no signal 25 15
gene loss 61 61
The ratio of the loss of p16 gene are equal.and any accompanying images. A copy of the written
consent is available for review by the Editor-in-Chief of
this journal.
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